Mark P. Carthy
Fondatore presso Orion Equity Partners LLC
Profilo
Mr. Mark P.
Carthy is Managing Partner at Orion Equity Partners LLC.
He is on the Board of Directors at Rexahn Pharmaceuticals, Inc., Xanthus Pharmaceuticals, Inc., Antolrx, Inc. and Scion Pharmaceuticals, Inc.
Mr. Carthy was previously employed as Chairman by Cyberkinetics Neurotechnology Systems, Inc., General Partner by Oxford Bioscience Partners, Chairman by Artesian Therapeutics, Inc., Chief Business Officer by Cubist Pharmaceuticals, Inc., a Principal by Morningside Venture Group LLC, and Non-Executive Director by PowderMed Ltd.
He also served on the board at Astex Therapeutics Ltd., Dendreon Corp., Dynogen Pharmaceuticals, Inc., Ensemble Therapeutics Corp., ImpactRx, Inc., Solexa, Inc. and Variagenics, Inc.
Mr. Carthy received his undergraduate degree from the University College Dublin, a graduate degree from the University of Missouri and an MBA from Harvard Business School.
Posizioni attive di Mark P. Carthy
| Società | Posizione | Inizio |
|---|---|---|
Orion Equity Partners LLC
 Orion Equity Partners LLC Investment ManagersFinance Orion Equity Partners LLC (ORHEP) is a venture capital firm founded in 2008 by Mark P. Carthy. The firm is headquartered in Boston, Massachusetts. | Fondatore | 01/01/2008 |
Antolrx, Inc.
 Antolrx, Inc. BiotechnologyHealth Technology Antolrx, Inc. operates in the healthcare industry focusing on biotechnology business. The company was founded by Mark Carthy and is headquartered in Boston, MA. | Fondatore | 01/01/2015 |
Precedenti posizioni note di Mark P. Carthy
| Società | Posizione | Fine |
|---|---|---|
| REXAHN PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 14/06/2018 |
PowderMed Ltd.
 PowderMed Ltd. Pharmaceuticals: MajorHealth Technology PowderMed Ltd. develops immunotherapeutic products. It focuses on the clinical development and manufacture of therapeutic and prophylactic DNA-based vaccines for viral diseases and cancer. The company has 4 clinical and 3 pre-clinical stage projects. The company was founded February 25, 2004 by Dr. Clive Dix & Dr. Beadle and is headquartered at Oxford, The United Kingdom. | Direttore/Membro del Consiglio | 15/05/2008 |
Cyberkinetics Neurotechnology Systems, Inc.
 Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Presidente | 18/04/2008 |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Investitore di Private Equity | 31/10/2007 |
Solexa, Inc.
 Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | Direttore/Membro del Consiglio | 26/01/2007 |
Formazione di Mark P. Carthy
| University of Missouri | Graduate Degree |
| University College Dublin | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 20 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Finance |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Health Technology |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Process Industries |
ImpactRx, Inc.
 ImpactRx, Inc. Miscellaneous Commercial ServicesCommercial Services ImpactRx, Inc. was provided health-care sector custom research and promotional consultancy services. The company was founded by Lawrence G. Miller, Terry Overton and Gerald J. Gallivan in 2000 and was headquartered in Horsham, PA. | Commercial Services |
Faraday Pharmaceuticals, Inc. (Washington)
 Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA. | Retail Trade |
Artesian Therapeutics, Inc.
 Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Health Technology |
Variagenics, Inc.
 Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care through both biopharmaceutical collaborations and its own internal research programs | Commercial Services |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
PowderMed Ltd.
PowderMed Ltd. Pharmaceuticals: MajorHealth Technology PowderMed Ltd. develops immunotherapeutic products. It focuses on the clinical development and manufacture of therapeutic and prophylactic DNA-based vaccines for viral diseases and cancer. The company has 4 clinical and 3 pre-clinical stage projects. The company was founded February 25, 2004 by Dr. Clive Dix & Dr. Beadle and is headquartered at Oxford, The United Kingdom. | Health Technology |
Antisoma, Inc.
 Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Health Technology |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Health Technology |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | Health Technology |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
Orion Equity Partners LLC
Orion Equity Partners LLC Investment ManagersFinance Orion Equity Partners LLC (ORHEP) is a venture capital firm founded in 2008 by Mark P. Carthy. The firm is headquartered in Boston, Massachusetts. | Finance |
Antolrx, Inc.
Antolrx, Inc. BiotechnologyHealth Technology Antolrx, Inc. operates in the healthcare industry focusing on biotechnology business. The company was founded by Mark Carthy and is headquartered in Boston, MA. | Health Technology |
1efficiency, Inc.
 1efficiency, Inc. Packaged SoftwareTechnology Services 1efficiency, Inc. develops cloud-based energy management consumption database and portfolio to save energy. The firm produces products under the brand names such as Energy Insight, Energy Reports, Peak Demand Alerts, Energy Saving Concierge, Energy Consumption Database and Energy Portfolio Builder. The company was founded by Giroti Tony and is headquartered in Newton, MA. | Technology Services |
Savran Technologies, Inc.
 Savran Technologies, Inc. BiotechnologyHealth Technology Savran Technologies, Inc. provide and develops a technology to isolate ultra-rare cells from blood. The company was founded by Cagri Savran in 2018 and is headquartered in Cambridge, MA. | Health Technology |
Morningside Venture Group LLC
 Morningside Venture Group LLC Food RetailRetail Trade Morningside Venture Group LLC owns and operates a chain of donut stores. It also operates Dunkin' Donuts stores covering major parts of the Orlando city in Florida. The company was founded in September 2007 and is headquartered in Norwood, MA. | Retail Trade |
- Borsa valori
- Insiders
- Mark P. Carthy
